The percentage of CD3+CD4+IFN-gamma+ T cells displayed a significant 4-fold reduction in the severe COVID-19 group compared to participants developing a mild disease (P = 0.0034) (Figure 2E). This evidence concerns the gene IFNG and COVID-19.